pGL4-hACLY promoter
(Plasmid
#251827)
-
PurposeExpresses luciferase under human ACLY promoter to measure its activity in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 251827 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepGL4.10
-
Backbone manufacturerPromega
- Backbone size w/o insert (bp) 4242
- Total vector size (bp) 5200
-
Vector typeMammalian Expression, Luciferase
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameACLY promoter
-
Alt namehg38; chr17: 41918547-41919547
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1007
-
Entrez GeneACLY (a.k.a. ACL, ATPCL, CLATP)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site KpnI (not destroyed)
- 3′ cloning site KpnI (not destroyed)
- 5′ sequencing primer NA
- (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGL4-hACLY promoter was a gift from Daniel Herranz (Addgene plasmid # 251827 ; http://n2t.net/addgene:251827 ; RRID:Addgene_251827) -
For your References section:
A feedforward loop between ACLY and MYC supports T-ALL progression in vivo. da Silva-Diz V, Singh A, Aleksandrova M, Kim O, Thai C, Lancho O, Renck Nunes P, Affronti H, Martinez de Paz A, Josefowicz SZ, Su X, Wellen KE, Herranz D. Blood Neoplasia. 2025 Jan 20;2(2):100069. doi: 10.1016/j.bneo.2025.100069. eCollection 2025 May. 10.1016/j.bneo.2025.100069 PubMed 40453140